Billy Joel announced in a statement that he will be postponing his tour dates for four months due to a "medical condition," ...

NEW YORK, NY / ACCESS Newswire / March 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a ...

Angelina Marie, 30, who is a full-time mother-of-two from Mississippi, wanted to slim down after seeing her weight balloon to ...

Novo Nordisk's REDEFINE 2 trial shows CagriSema led to significant weight loss in patients with obesity and type 2 diabetes. Regulatory filing is planned for 2026.

Longevity doctor reveals common Ozempic mistakes affecting adults over 50, including protein deficiency, mental health risks, and muscle loss. Learn proper usage.

Jim Owen, who spent 35 years on Wall Street, was goal-oriented but couldn't find the motivation to exercise. Now at age 84, ...

If it wasn’t one thing, it was the other, the Lakers losing to the lottery-bound Brooklyn Nets, with tougher days headed ...

Whether it’s Ozempic, Pilates, or sheer will, celebrity transformations take all shapes and sizes - so what's the hassle all ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

Lloyd's of London said on Monday it expected $2.3 billion in net losses caused by the recent Los Angeles wildfires, as the ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...